[Translation] Bioequivalence study of sildenafil citrate orodisintegrating tablets in healthy volunteers
本试验旨在研究健康受试者单次空腹口服北京星昊盈盛药业有限公司研制、生产的枸橼酸西地那非口崩片(50 mg)的药代动力学特征;以Upjohn EESV持证、Fareva Amboise生产的枸橼酸西地那非口崩片(万艾可®,50 mg)为参比制剂,比较两制剂中的药动学参数,评价两制剂的人体生物等效性,并观察两制剂在健康受试者中的安全性。
[Translation] The purpose of this study was to study the pharmacokinetic characteristics of a single fasting oral administration of sildenafil citrate orodisintegrating tablets (50 mg) developed and produced by Beijing Xinghao Yingsheng Pharmaceutical Co., Ltd. in healthy subjects; using sildenafil citrate orodisintegrating tablets (Viagra®, 50 mg) certified by Upjohn EESV and produced by Fareva Amboise as the reference preparation, to compare the pharmacokinetic parameters of the two preparations, evaluate the human bioequivalence of the two preparations, and observe the safety of the two preparations in healthy subjects.
100 Clinical Results associated with Beijing Xinghao Yingsheng Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Beijing Xinghao Yingsheng Pharmaceutical Co., Ltd.
100 Deals associated with Beijing Xinghao Yingsheng Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Beijing Xinghao Yingsheng Pharmaceutical Co., Ltd.